DexCom
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
DexCom (DXCM) Business News
Track DexCom in real time with a live news feed covering DexCom stock news, official press releases, company announcements, and an archive of historical DexCom news. ...more
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Here's Why DexCom (DXCM) is a Strong Growth Stock
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Exchange Traded Concepts LLC Sells 8,031 Shares of DexCom, Inc. $DXCM
Financial Analysis: Pacific Biosciences of California (NASDAQ:PACB) versus DexCom (NASDAQ:DXCM)
Banque Pictet & Cie SA Raises Stock Holdings in DexCom, Inc. $DXCM
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
DexCom, Inc. $DXCM Shares Sold by Beacon Investment Advisory Services Inc.
Contrasting DexCom (NASDAQ:DXCM) and LENSAR (NASDAQ:LNSR)
Sysmex (OTCMKTS:SSMXY) vs. DexCom (NASDAQ:DXCM) Head to Head Survey
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Here's Why DexCom (DXCM) is a Strong Growth Stock
10:46 AM | Tuesday | Apr 14, 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
Here's Why DexCom (DXCM) is a Strong Growth Stock
Zacks Investment ResearchWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read full article
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
PRNewsWireShareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Read full article
Exchange Traded Concepts LLC Sells 8,031 Shares of DexCom, Inc. $DXCM
Defense WorldExchange Traded Concepts LLC lessened its position in shares of DexCom, Inc. (NASDAQ: DXCM) by 80.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,000 shares of the medical device company's stock after selling 8,031 shares during the period. Exchange Traded Concepts
Read full article
Financial Analysis: Pacific Biosciences of California (NASDAQ:PACB) versus DexCom (NASDAQ:DXCM)
Defense WorldPacific Biosciences of California (NASDAQ: PACB - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, valuation and profitability. Volatility and Risk Pacific Biosciences of California
Read full article
Banque Pictet & Cie SA Raises Stock Holdings in DexCom, Inc. $DXCM
Defense WorldBanque Pictet and Cie SA boosted its holdings in shares of DexCom, Inc. (NASDAQ: DXCM) by 58.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 109,823 shares of the medical device company's stock after purchasing an additional 40,411 shares during the
Read full article
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
Business WireSAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will hold a conference call to review the company's first quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day.
The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will.
DexCom, Inc. $DXCM Shares Sold by Beacon Investment Advisory Services Inc.
Defense WorldBeacon Investment Advisory Services Inc. reduced its stake in DexCom, Inc. (NASDAQ: DXCM) by 12.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 272,836 shares of the medical device company's stock after selling 37,468 shares during the period.
Beacon Investment
Contrasting DexCom (NASDAQ:DXCM) and LENSAR (NASDAQ:LNSR)
Defense WorldDexCom (NASDAQ: DXCM - Get Free Report) and LENSAR (NASDAQ: LNSR - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Volatility and Risk DexCom has a beta of 1.48, suggesting
Read full article
Sysmex (OTCMKTS:SSMXY) vs. DexCom (NASDAQ:DXCM) Head to Head Survey
Defense WorldSysmex (OTCMKTS:SSMXY - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership. Profitability This table compares Sysmex and DexCom's net margins, return
Read full article
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
Zacks Investment ResearchThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read full article